急性腎不全の世界市場レポート 2025年

急性腎不全市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は6.5％で、73億9,000万米ドルに成長します。予測期間中の成長の原動力は、敗血症の罹患率の増加、個別化治療に対する需要の高まり、政府のヘルスケアイニシアチブの拡大、新興市場における医療支出の増加、個別化医療と再生治療の重視です。この期間に予想される主な動向には、ウェアラブル透析機器の開発、治療最適化のための人工知能の統合、携帯型腎代替療法システムの発展、持続的腎代替療法（CRRT）の革新、遠隔モニタリングと遠隔医療ソリューションの拡大などがあります。

糖尿病の有病率の増加は、急性腎不全（AKI）市場の拡大を促進すると予想されます。糖尿病は、血糖値の上昇を特徴とする代謝性疾患の一群を包含しており、その原因はインスリンの分泌不足またはインスリンを効果的に使用できない体質です。糖尿病の罹患率の増加は、肥満率の増加、食生活の乱れ、座りがちなライフスタイル、高齢化、認知度や診断能力の向上などの要因によるものです。急性腎不全は、インスリン抵抗性とグルコース調節に影響を与えうる代謝的・炎症的変化を誘発し、糖尿病の管理と進行に影響を与えうる複雑な関係を作り出します。例えば、2024年3月、英国の政府機関であるOffice for Health Improvement &Disparitiesは、2022年3月と2023年3月の間に、1型糖尿病患者が推奨される8つのケアプロセスをすべて受けた割合は22％増加し、2型糖尿病では21％増加したと報告しました。さらに、HbA1cの目標値を達成した人の割合は37.9%に達し、全国糖尿病監査（NDA）が記録した中で最も高い数値となりました。その結果、糖尿病有病率の上昇が急性腎不全市場の成長に拍車をかけています。

急性腎不全（AKI）市場の主要企業は、製品ラインナップの拡大や新規治療ソリューションの導入のため、規制当局の承認を優先しています。FDAやEMAのような機関から与えられる規制上の承認は、製品が市場に出る前に厳しい安全性、有効性、品質基準を満たしていることを確認するものです。例えば、2023年12月、英国のバイオテクノロジー企業であるMission Therapeutics Ltd.は、心臓手術後の高リスク患者を対象とした主要資産であるMTX652の第II相臨床試験を開始するためのFDA承認を取得しました。MTX652は、腎臓の損傷と修復に関与する主要な経路を標的とするように設計されており、炎症を抑え、腎臓のさらなる損傷を防ぎ、回復を促進することを目的としています。この試験の特徴は、AKIの分子的原因に対処する新規の治療メカニズムに焦点を当てていることであり、現在の治療法と比較してより効果的な治療選択肢を提供する可能性があります。第II相試験では、MTX652の安全性、有効性、薬物動態を評価し、より広範な臨床使用と最終的な規制当局の承認を支援しうる重要なデータを作成します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界急性腎不全 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の急性腎不全市場：成長率分析
• 世界の急性腎不全市場の実績：規模と成長, 2019-2024
• 世界の急性腎不全市場の予測：規模と成長, 2024-2029, 2034F
• 世界急性腎不全総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の急性腎不全市場怪我により、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腎前腎障害
• 腎後腎障害
• 内因性腎損傷
• 世界の急性腎不全市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 透析
• 薬物療法
• 尿路インプラント
• 世界の急性腎不全市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 外来手術センター
• その他のエンドユーザー
• 世界の急性腎不全市場腎前性腎障害の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血液量減少
• 心不全関連の傷害
• 敗血症誘発性傷害
• 腎動脈狭窄
• 肝腎症候群
• 世界の急性腎不全市場腎後腎障害のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 尿管閉塞
• 膀胱出口閉塞
• 前立腺肥大（良性前立腺肥大症）
• 腎臓結石
• 尿路を侵す腫瘍
• 世界の急性腎不全市場、内因性腎障害のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 急性尿細管壊死（ATN）
• 急性間質性腎炎（AIN）
• 糸球体腎炎
• 血管炎
• 横紋筋融解症による傷害

第7章 地域別・国別分析

• 世界の急性腎不全市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の急性腎不全市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 急性腎不全市場：競合情勢
• 急性腎不全市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novartis AG
• Eli Lilly and Company
• Gilead Sciences Inc.
• Amgen Inc.
• Fresenius Medical Care AG & Co. KGaA
• Asahi Kasei Medical Co. Ltd.
• Teva Pharmaceutical Industries Ltd.
• Baxter International Inc.
• B. Braun Melsungen AG
• Nipro Corporation
• Nikkiso Co. Ltd.
• Quark Pharmaceuticals Inc.
• Kringle Pharma Inc.
• Aptabio Therapeutics Inc.
• Alexion Pharmaceuticals Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 急性腎不全市場2029：新たな機会を提供する国
• 急性腎不全市場2029：新たな機会を提供するセグメント
• 急性腎不全市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Acute kidney injury (AKI) is characterized by a sudden decline in kidney function, resulting in the buildup of waste products, electrolytes, and fluids within the body. It can develop within hours or days and is commonly triggered by factors such as reduced blood flow, direct kidney damage, or urinary tract obstruction.

The primary types of acute kidney injury include pre-renal, post-renal, and intrinsic kidney injury. Pre-renal kidney injury occurs due to a significant reduction in blood flow to the kidneys, leading to impaired filtration. Treatment options include dialysis, drug therapy, and urinary implants, serving end users such as hospitals, ambulatory surgical centers, and other healthcare facilities.

The acute kidney injury market research report is one of a series of new reports from The Business Research Company that provides acute kidney injury market statistics, including acute kidney injury industry global market size, regional shares, competitors with an acute kidney injury market share, detailed acute kidney injury market segments, market trends and opportunities, and any further data you may need to thrive in the acute kidney injury industry. This acute kidney injury market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The acute kidney injury market size has grown strongly in recent years. It will grow from $5.37 billion in 2024 to $5.74 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth during the historic period can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, growing incidence of hospital-acquired infections, increasing awareness about kidney health, and advancements in critical care medicine.

The acute kidney injury market size is expected to see strong growth in the next few years. It will grow to $7.39 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The projected growth during the forecast period is driven by the increasing incidence of sepsis, rising demand for personalized treatment, expanding government healthcare initiatives, growing healthcare expenditure in emerging markets, and a strong emphasis on personalized medicine and regenerative therapies. Key trends expected during this period include the development of wearable dialysis devices, the integration of artificial intelligence for treatment optimization, advancements in portable renal replacement therapy systems, innovations in continuous renal replacement therapy (CRRT), and the expansion of remote monitoring and telemedicine solutions.

The increasing prevalence of diabetes is expected to drive the expansion of the acute kidney injury (AKI) market. Diabetes encompasses a group of metabolic diseases characterized by elevated blood sugar levels, either due to insufficient insulin production or the body's inability to use insulin effectively. The rising incidence of diabetes is attributed to factors such as increasing obesity rates, poor dietary habits, sedentary lifestyles, aging populations, and improved awareness and diagnostic capabilities. Acute kidney injury induces metabolic and inflammatory changes that can impact insulin resistance and glucose regulation, creating a complex relationship that may affect diabetes management and progression. For example, in March 2024, the Office for Health Improvement & Disparities, a UK-based government department, reported that between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes increased by 22%, while for type 2 diabetes, it increased by 21%. Additionally, the proportion of individuals achieving target HbA1c levels reached 37.9%, marking the highest figure ever recorded by the National Diabetes Audit (NDA). Consequently, the rising prevalence of diabetes is fueling the growth of the acute kidney injury market.

Leading companies in the acute kidney injury (AKI) market are prioritizing regulatory approvals to expand their product offerings and introduce novel treatment solutions. Regulatory approvals, granted by bodies such as the FDA or EMA, confirm that a product meets stringent safety, efficacy, and quality standards before entering the market. For instance, in December 2023, Mission Therapeutics Ltd., a UK-based biotechnology company, received FDA approval to initiate a Phase II clinical trial for its lead asset, MTX652, targeting acute kidney injury in high-risk patients following cardiac surgery. MTX652 is designed to target key pathways involved in kidney injury and repair, with the goal of reducing inflammation, preventing further kidney damage, and promoting recovery. A distinctive aspect of this trial is its focus on novel therapeutic mechanisms that address the molecular causes of AKI, potentially offering more effective treatment options compared to current interventions. The Phase II trial will assess MTX652's safety, efficacy, and pharmacokinetics, generating critical data that could support broader clinical use and eventual regulatory approval.

In July 2022, Terumo Blood and Cell Technologies, a US-based medical equipment manufacturer, partnered with Eliaz Therapeutics Inc. to develop an innovative therapeutic apheresis treatment for acute kidney injury (AKI) and sepsis-induced AKI (S-AKI). This treatment is designed to selectively remove the inflammatory protein Galectin-3 from blood plasma, with the objective of improving patient outcomes, reducing the risk of chronic kidney disease, and lowering hospital mortality rates. Eliaz Therapeutics Inc. is a US-based developer of medical devices specializing in innovative treatments for AKI and S-AKI.

Major players in the acute kidney injury market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Medical Co. Ltd., Teva Pharmaceutical Industries Ltd., Baxter International Inc., B. Braun Melsungen AG, Nipro Corporation, Nikkiso Co. Ltd., Quark Pharmaceuticals Inc., Kringle Pharma Inc., Aptabio Therapeutics Inc., Alexion Pharmaceuticals Inc., Alloksys Life Sciences B.V., AM-Pharma B.V., Arch Biopartners Inc., Guard Therapeutics International AB.

North America was the largest region in the acute kidney injury market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in acute kidney injury report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the acute kidney injury market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The acute kidney injury market includes revenues earned by entities by providing services such as urinalysis & biomarker testing, imaging services, dialysis services, and surgical & interventional procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Acute Kidney Injury Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on acute kidney injury market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for acute kidney injury ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The acute kidney injury market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Injury: Pre-Renal Kidney Injury; Post-Renal Kidney Injury; Intrinsic Kidney Injury
• 2) By Treatment Type: Dialysis; Drug Therapy; Urinary Implants
• 3) By End User: Hospitals; Ambulatory Surgical Centers; Other End Users
• Subsegments:
• 1) By Pre-Renal Kidney Injury: Hypovolemia; Heart Failure-Related Injury; Sepsis-Induced Injury; Renal Artery Stenosis; Hepatorenal Syndrome
• 2) By Post-Renal Kidney Injury: Ureteral Obstruction; Bladder Outlet Obstruction; Prostate Enlargement (Benign Prostatic Hyperplasia); Kidney Stones; Tumors Affecting Urinary Tract
• 3) By Intrinsic Kidney Injury: Acute Tubular Necrosis (ATN); Acute Interstitial Nephritis (AIN); Glomerulonephritis; Vasculitis; Rhabdomyolysis-Induced Injury
• Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd; Merck & Co. Inc.; Sanofi S.A.; Bristol-Myers Squibb Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Acute Kidney Injury Market Characteristics

3. Acute Kidney Injury Market Trends And Strategies

4. Acute Kidney Injury Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Acute Kidney Injury Growth Analysis And Strategic Analysis Framework

• 5.1. Global Acute Kidney Injury PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Acute Kidney Injury Market Growth Rate Analysis
• 5.4. Global Acute Kidney Injury Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Acute Kidney Injury Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Acute Kidney Injury Total Addressable Market (TAM)

6. Acute Kidney Injury Market Segmentation

• 6.1. Global Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pre-Renal Kidney Injury
• Post-Renal Kidney Injury
• Intrinsic Kidney Injury
• 6.2. Global Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dialysis
• Drug Therapy
• Urinary Implants
• 6.3. Global Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Other End Users
• 6.4. Global Acute Kidney Injury Market, Sub-Segmentation Of Pre-Renal Kidney Injury, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hypovolemia
• Heart Failure-Related Injury
• Sepsis-Induced Injury
• Renal Artery Stenosis
• Hepatorenal Syndrome
• 6.5. Global Acute Kidney Injury Market, Sub-Segmentation Of Post-Renal Kidney Injury, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ureteral Obstruction
• Bladder Outlet Obstruction
• Prostate Enlargement (Benign Prostatic Hyperplasia)
• Kidney Stones
• Tumors Affecting Urinary Tract
• 6.6. Global Acute Kidney Injury Market, Sub-Segmentation Of Intrinsic Kidney Injury, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Tubular Necrosis (ATN)
• Acute Interstitial Nephritis (AIN)
• Glomerulonephritis
• Vasculitis
• Rhabdomyolysis-Induced Injury

7. Acute Kidney Injury Market Regional And Country Analysis

• 7.1. Global Acute Kidney Injury Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Acute Kidney Injury Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Acute Kidney Injury Market

• 8.1. Asia-Pacific Acute Kidney Injury Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Acute Kidney Injury Market

• 9.1. China Acute Kidney Injury Market Overview
• 9.2. China Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Acute Kidney Injury Market

• 10.1. India Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Acute Kidney Injury Market

• 11.1. Japan Acute Kidney Injury Market Overview
• 11.2. Japan Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Acute Kidney Injury Market

• 12.1. Australia Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Acute Kidney Injury Market

• 13.1. Indonesia Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Acute Kidney Injury Market

• 14.1. South Korea Acute Kidney Injury Market Overview
• 14.2. South Korea Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Acute Kidney Injury Market

• 15.1. Western Europe Acute Kidney Injury Market Overview
• 15.2. Western Europe Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Acute Kidney Injury Market

• 16.1. UK Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Acute Kidney Injury Market

• 17.1. Germany Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Acute Kidney Injury Market

• 18.1. France Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Acute Kidney Injury Market

• 19.1. Italy Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Acute Kidney Injury Market

• 20.1. Spain Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Acute Kidney Injury Market

• 21.1. Eastern Europe Acute Kidney Injury Market Overview
• 21.2. Eastern Europe Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Acute Kidney Injury Market

• 22.1. Russia Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Acute Kidney Injury Market

• 23.1. North America Acute Kidney Injury Market Overview
• 23.2. North America Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Acute Kidney Injury Market

• 24.1. USA Acute Kidney Injury Market Overview
• 24.2. USA Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Acute Kidney Injury Market

• 25.1. Canada Acute Kidney Injury Market Overview
• 25.2. Canada Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Acute Kidney Injury Market

• 26.1. South America Acute Kidney Injury Market Overview
• 26.2. South America Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Acute Kidney Injury Market

• 27.1. Brazil Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Acute Kidney Injury Market

• 28.1. Middle East Acute Kidney Injury Market Overview
• 28.2. Middle East Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Acute Kidney Injury Market

• 29.1. Africa Acute Kidney Injury Market Overview
• 29.2. Africa Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Acute Kidney Injury Market Competitive Landscape And Company Profiles

• 30.1. Acute Kidney Injury Market Competitive Landscape
• 30.2. Acute Kidney Injury Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Acute Kidney Injury Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Eli Lilly and Company
• 31.3. Gilead Sciences Inc.
• 31.4. Amgen Inc.
• 31.5. Fresenius Medical Care AG & Co. KGaA
• 31.6. Asahi Kasei Medical Co. Ltd.
• 31.7. Teva Pharmaceutical Industries Ltd.
• 31.8. Baxter International Inc.
• 31.9. B. Braun Melsungen AG
• 31.10. Nipro Corporation
• 31.11. Nikkiso Co. Ltd.
• 31.12. Quark Pharmaceuticals Inc.
• 31.13. Kringle Pharma Inc.
• 31.14. Aptabio Therapeutics Inc.
• 31.15. Alexion Pharmaceuticals Inc.

32. Global Acute Kidney Injury Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Acute Kidney Injury Market

34. Recent Developments In The Acute Kidney Injury Market

35. Acute Kidney Injury Market High Potential Countries, Segments and Strategies

• 35.1 Acute Kidney Injury Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Acute Kidney Injury Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Acute Kidney Injury Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer